Express Scripts-Medco Specialty Drug Market Share Would Exceed 52%

The combination of Medco’s market-leading specialty drug pharmacy unit, Accredo, with Express Scripts’ specialty businesses would create a dominant player controlling more than 52% of the market, based on research by Pembroke Consulting.